Skip to content
Screener

CG Oncology CGON Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$79.06M-90.8%-$60.2M-74.7%-$41.31M-29.9%-$43.81M-115%-$41.43M-119%
$850K+445%$841K+3,404%$849K$416K+1,881%$156K+2,129%
$14.33M+105%$6.47M+25.7%$7.19M+44.0%$7.33M+177%$7.01M+212%
-$46.41M-66.0%-$56.94M-94.5%-$36.22M-75.3%-$38.89M-144%-$27.96M-73.4%
$468K+3,243%$304K+1,800%$7K-96.7%$97K$14K0.0%
-$334.85M-79.3%-$75.51M
$1.92M$393M+87,233%$99.07M-55.7%$54.37M+2,409%$0-100%
-$14.06M+47.6%$1.21M+101%-$12.66M-106%-$26.85M
-$46.88M-67.6%-$57.25M-95.4%-$36.22M-73.6%-$38.99M-145%-$27.97M-73.4%

FAQ

How much cash does CG Oncology generate?
CG Oncology (CGON) generated -$178.5M in operating cash flow over the trailing twelve months.
What is CG Oncology's free cash flow?
After $876.0K of capital expenditures, CG Oncology's free cash flow was -$179.3M over the trailing twelve months, down 90.7% year over year.
Where does CG Oncology's cash flow data come from?
Every line is extracted from CG Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.